Axa’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-79,392
Closed -$5.07M 1175
2025
Q1
$5.07M Buy
79,392
+20,540
+35% +$1.31M 0.02% 535
2024
Q4
$7.16M Sell
58,852
-93
-0.2% -$11.3K 0.02% 452
2024
Q3
$7.36M Buy
58,945
+18
+0% +$2.25K 0.02% 456
2024
Q2
$9.31M Buy
58,927
+33
+0.1% +$5.21K 0.03% 401
2024
Q1
$7.62M Buy
58,894
+15
+0% +$1.94K 0.02% 461
2023
Q4
$5.68M Sell
58,879
-1,425
-2% -$137K 0.02% 524
2023
Q3
$7.31M Sell
60,304
-214
-0.4% -$25.9K 0.03% 456
2023
Q2
$6.93M Buy
60,518
+833
+1% +$95.4K 0.02% 483
2023
Q1
$8.23M Sell
59,685
-37,889
-39% -$5.22M 0.03% 449
2022
Q4
$12.6M Sell
97,574
-531
-0.5% -$68.8K 0.05% 390
2022
Q3
$10.8M Buy
98,105
+413
+0.4% +$45.7K 0.04% 416
2022
Q2
$7.32M Sell
97,692
-1,904
-2% -$143K 0.03% 492
2022
Q1
$7.78M Sell
99,596
-1
-0% -$78 0.02% 536
2021
Q4
$8.97M Buy
99,597
+1,190
+1% +$107K 0.02% 525
2021
Q3
$9.1M Buy
98,407
+3,617
+4% +$335K 0.03% 522
2021
Q2
$7.37M Sell
94,790
-7,199
-7% -$560K 0.02% 599
2021
Q1
$7.6M Buy
101,989
+30,107
+42% +$2.24M 0.02% 584
2020
Q4
$12.3M Buy
71,882
+2,897
+4% +$494K 0.04% 453
2020
Q3
$9.69M Sell
68,985
-6,005
-8% -$843K 0.04% 469
2020
Q2
$12M Buy
74,990
+8,319
+12% +$1.33M 0.05% 385
2020
Q1
$6.52M Buy
66,671
+3,715
+6% +$363K 0.03% 456
2019
Q4
$8.12M Buy
62,956
+1,470
+2% +$190K 0.03% 496
2019
Q3
$4.63M Sell
61,486
-99
-0.2% -$7.46K 0.02% 676
2019
Q2
$9.36M Sell
61,585
-20,776
-25% -$3.16M 0.04% 491
2019
Q1
$9.82M Sell
82,361
-4,600
-5% -$548K 0.04% 462
2018
Q4
$9.49M Sell
86,961
-100
-0.1% -$10.9K 0.04% 430
2018
Q3
$14.1M Sell
87,061
-46
-0.1% -$7.43K 0.05% 385
2018
Q2
$11.5M Buy
87,107
+27,514
+46% +$3.64M 0.04% 409
2018
Q1
$4.42M Buy
+59,593
New +$4.42M 0.02% 686
2015
Q1
Sell
-84,400
Closed -$1.22M 1486
2014
Q4
$1.22M Buy
+84,400
New +$1.22M ﹤0.01% 921